コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 and were not directly related to the use of enamel matrix derivative.
2 ins, known to be present in some mixtures of enamel matrix derivatives.
3 h a bone replacement graft [combination], or enamel matrix derivative), according to predefined crite
6 rformed utilizing water-jet decontamination, enamel matrix derivative, and locally harvested autogeno
7 xenograft used alone and in combination with enamel matrix derivative are effective for the treatment
8 h >/= 4 mm) was treated regeneratively using enamel matrix derivative at two centers (Frankfurt am Ma
9 utilizing collagen membrane, with or without enamel matrix derivative, can be successfully used in ob
10 d bone allograft (DFDBA) in combination with enamel matrix derivative (EMD + DFDBA) compared to ename
11 rafts (ADMG) + CAF and SCTG + CAF or between enamel matrix derivative (EMD) + CAF and SCTG + CAF.
12 clinical trial was that local application of enamel matrix derivative (EMD) added to papilla reflecti
13 matrix derivative (EMD + DFDBA) compared to enamel matrix derivative (EMD) alone in the treatment of
18 periodontal surgery using the combination of enamel matrix derivative (EMD) and natural bone mineral
20 ly autogenous blood-dervied products (ABPs), enamel matrix derivative (EMD) and recombinant human pla
24 In this study, we compare the effects of enamel matrix derivative (EMD) associated with a hydroxy
25 this study, we compare the effectiveness of enamel matrix derivative (EMD) associated with a simplif
26 sidering xenogeneic collagen matrix (CM) and enamel matrix derivative (EMD) characteristics, it is su
27 s study was to evaluate the effectiveness of enamel matrix derivative (EMD) combined with a bovine-de
28 ctice reports on the clinical efficacy of an enamel matrix derivative (EMD) combined with either demi
31 ally, the use of collagen matrix (CM) and/or enamel matrix derivative (EMD) for the treatment of dehi
47 ized freeze-dried bone allograft (DFDBA) and enamel matrix derivative (EMD) have been used with varyi
48 ith a xenogenous collagen matrix (CM) and/or enamel matrix derivative (EMD) in combination with a cor
50 nnective tissue graft (CTG) with and without enamel matrix derivative (EMD) in the treatment of multi
51 he large body of evidence on the efficacy of enamel matrix derivative (EMD) in the treatment of perio
52 he large body of evidence on the efficacy of enamel matrix derivative (EMD) in the treatment of perio
57 this study was to determine the effect of an enamel matrix derivative (EMD) on cementoblast behavior
58 cemento-inductivity effect of calcitriol and enamel matrix derivative (EMD) on human periodontal liga
59 of this study is to determine the impact of enamel matrix derivative (EMD) on superoxide (O(2)(-)) g
60 ellular dermal matrix (ADM) with and without enamel matrix derivative (EMD) on the percentage of root
61 radiographic and patient-centered results of enamel matrix derivative (EMD) therapy in intrabony defe
62 have been demonstrated with the addition of enamel matrix derivative (EMD) to demineralized freeze-d
66 neutral ethylene diamine tetracetic acid and enamel matrix derivative (EMD) were first used to treat
68 modality as compared with the association of enamel matrix derivative (EMD) with ABG in the managemen
69 milarly, in guided tissue regeneration (GTR)/enamel matrix derivative (EMD) with and without laser tr
70 inical studies suggest that a combination of enamel matrix derivative (EMD) with demineralized freeze
71 have also demonstrated the efficacy of using enamel matrix derivative (EMD) with demineralized freeze
72 of periodontal regeneration treatments with enamel matrix derivative (EMD), a commercial formulation
73 ontaining different concentrations of either enamel matrix derivative (EMD), amelogenin, platelet-der
74 of autologous blood-derived products (ABPs), enamel matrix derivative (EMD), recombinant human platel
75 of autologous blood-derived products (ABPs), enamel matrix derivative (EMD), recombinant human platel
76 m of this study is to evaluate the effect of enamel matrix derivative (EMD), tyrosine-rich amelogenin
83 ly autologous blood-derived products (ABPs), enamel matrix derivatives (EMD) and recombinant human pl
84 enic (bone morphogenetic protein [BMP]-2 and enamel matrix derivative [EMD]) were compared to a contr
87 logenin fraction of porcine enamel matrix in enamel matrix derivative (i.e., AMEL) is not antibacteri
88 from the same surgical site was treated with enamel matrix derivative in a dampen dish and then added
89 n enhancement of hard tissue parameters when enamel matrix derivative is added to demineralized freez
90 ort the concept that clinical application of enamel matrix derivative may enhance periodontal wound r
91 Adjunctive autologous bone grafting with enamel matrix derivative might be significantly benefici
92 ed flap plus acellular dermal matrix grafts, enamel matrix derivative, or collagen matrix led to the
93 tudy was to compare the clinical efficacy of enamel matrix derivative placed under a coronally advanc
94 ogics in root coverage procedures, including enamel matrix derivative, platelet-derived growth factor
96 cept for MRC at the 12-month follow-up where enamel matrix derivative plus CAF exhibited superior res
97 ve tissue grafts (SCTGs), matrix grafts, and enamel matrix derivative protein (EMD) procedures were s
98 A recent study suggests that the addition of enamel matrix derivative to demineralized freeze-dried b
99 he results of this study, the application of enamel matrix derivative to denuded root surfaces receiv
100 of a commercially prepared embryonic porcine enamel matrix derivative to induce new bone formation in
103 se histologic sections strongly suggest that enamel matrix derivative works in a biomimetic fashion b